Staining:Article Title: Evaluating Therapeutic Efficacy of the Vascular Disrupting Agent OXi8007 Against Kidney Cancer in Mice
Article Snippet: Renca mouse kidney cancer cells (ATCC) and Renca-luc cells [55] were grown in RPMI1640 media supplemented with 10% qualified FBS, sodium pyruvate, MEM non-essential amino acids, L-glutamine, and Pen/Strep solution.. Cells were authenticated using the FTA Sample Collection Kit (ATCC, 137-XV) through the Mouse Cell Authentication Service at ATCC.Cells were authenticated using the FTA Sample Collection Kit (ATCC, 137-XV) through the Mouse Cell Authentication Service at ATCC.
Article Title: Evaluating Therapeutic Efficacy of the Vascular Disrupting Agent OXi8007 Against Kidney Cancer in Mice
Article Snippet: Renca mouse kidney cancer cells (ATCC) and Renca-luc cells [ ] were grown in RPMI-1640 media supplemented with 10% qualified FBS, sodium pyruvate, MEM non-essential amino acids, L -glutamine, and Pen/Strep solution.. Cells were authenticated using the FTA Sample Collection Kit (ATCC, 137-XV) through the Mouse Cell Authentication Service at ATCC.Cells were authenticated using the FTA Sample Collection Kit (ATCC, 137-XV) through the Mouse Cell Authentication Service at ATCC.
Disruption:Article Title: Evaluating Therapeutic Efficacy of the Vascular Disrupting Agent OXi8007 Against Kidney Cancer in Mice
Article Snippet: Renca mouse kidney cancer cells (ATCC) and Renca-luc cells [55] were grown in RPMI1640 media supplemented with 10% qualified FBS, sodium pyruvate, MEM non-essential amino acids, L-glutamine, and Pen/Strep solution.. Cells were authenticated using the FTA Sample Collection Kit (ATCC, 137-XV) through the Mouse Cell Authentication Service at ATCC.Cells were authenticated using the FTA Sample Collection Kit (ATCC, 137-XV) through the Mouse Cell Authentication Service at ATCC.
Article Title: Evaluating Therapeutic Efficacy of the Vascular Disrupting Agent OXi8007 Against Kidney Cancer in Mice
Article Snippet: Renca mouse kidney cancer cells (ATCC) and Renca-luc cells [ ] were grown in RPMI-1640 media supplemented with 10% qualified FBS, sodium pyruvate, MEM non-essential amino acids, L -glutamine, and Pen/Strep solution.. Cells were authenticated using the FTA Sample Collection Kit (ATCC, 137-XV) through the Mouse Cell Authentication Service at ATCC.Cells were authenticated using the FTA Sample Collection Kit (ATCC, 137-XV) through the Mouse Cell Authentication Service at ATCC.
In Situ:Article Title: Evaluating Therapeutic Efficacy of the Vascular Disrupting Agent OXi8007 Against Kidney Cancer in Mice
Article Snippet: Renca mouse kidney cancer cells (ATCC) and Renca-luc cells [55] were grown in RPMI1640 media supplemented with 10% qualified FBS, sodium pyruvate, MEM non-essential amino acids, L-glutamine, and Pen/Strep solution.. Cells were authenticated using the FTA Sample Collection Kit (ATCC, 137-XV) through the Mouse Cell Authentication Service at ATCC.Cells were authenticated using the FTA Sample Collection Kit (ATCC, 137-XV) through the Mouse Cell Authentication Service at ATCC.
Article Title: Evaluating Therapeutic Efficacy of the Vascular Disrupting Agent OXi8007 Against Kidney Cancer in Mice
Article Snippet: Renca mouse kidney cancer cells (ATCC) and Renca-luc cells [ ] were grown in RPMI-1640 media supplemented with 10% qualified FBS, sodium pyruvate, MEM non-essential amino acids, L -glutamine, and Pen/Strep solution.. Cells were authenticated using the FTA Sample Collection Kit (ATCC, 137-XV) through the Mouse Cell Authentication Service at ATCC.Cells were authenticated using the FTA Sample Collection Kit (ATCC, 137-XV) through the Mouse Cell Authentication Service at ATCC.
Control:Article Title: Evaluating Therapeutic Efficacy of the Vascular Disrupting Agent OXi8007 Against Kidney Cancer in Mice
Article Snippet: Renca mouse kidney cancer cells (ATCC) and Renca-luc cells [55] were grown in RPMI1640 media supplemented with 10% qualified FBS, sodium pyruvate, MEM non-essential amino acids, L-glutamine, and Pen/Strep solution.. Cells were authenticated using the FTA Sample Collection Kit (ATCC, 137-XV) through the Mouse Cell Authentication Service at ATCC.Cells were authenticated using the FTA Sample Collection Kit (ATCC, 137-XV) through the Mouse Cell Authentication Service at ATCC.
Article Title: Evaluating Therapeutic Efficacy of the Vascular Disrupting Agent OXi8007 Against Kidney Cancer in Mice
Article Snippet: Renca mouse kidney cancer cells (ATCC) and Renca-luc cells [ ] were grown in RPMI-1640 media supplemented with 10% qualified FBS, sodium pyruvate, MEM non-essential amino acids, L -glutamine, and Pen/Strep solution.. Cells were authenticated using the FTA Sample Collection Kit (ATCC, 137-XV) through the Mouse Cell Authentication Service at ATCC.Cells were authenticated using the FTA Sample Collection Kit (ATCC, 137-XV) through the Mouse Cell Authentication Service at ATCC.
Saline:Article Title: Evaluating Therapeutic Efficacy of the Vascular Disrupting Agent OXi8007 Against Kidney Cancer in Mice
Article Snippet: Renca mouse kidney cancer cells (ATCC) and Renca-luc cells [55] were grown in RPMI1640 media supplemented with 10% qualified FBS, sodium pyruvate, MEM non-essential amino acids, L-glutamine, and Pen/Strep solution.. Cells were authenticated using the FTA Sample Collection Kit (ATCC, 137-XV) through the Mouse Cell Authentication Service at ATCC.Cells were authenticated using the FTA Sample Collection Kit (ATCC, 137-XV) through the Mouse Cell Authentication Service at ATCC.
Article Title: Evaluating Therapeutic Efficacy of the Vascular Disrupting Agent OXi8007 Against Kidney Cancer in Mice
Article Snippet: Renca mouse kidney cancer cells (ATCC) and Renca-luc cells [ ] were grown in RPMI-1640 media supplemented with 10% qualified FBS, sodium pyruvate, MEM non-essential amino acids, L -glutamine, and Pen/Strep solution.. Cells were authenticated using the FTA Sample Collection Kit (ATCC, 137-XV) through the Mouse Cell Authentication Service at ATCC.Cells were authenticated using the FTA Sample Collection Kit (ATCC, 137-XV) through the Mouse Cell Authentication Service at ATCC.
|